Sigma Planning Corp Invests $29,000 in Clover Health Investments, Corp. (NASDAQ:CLOV)

Sigma Planning Corp bought a new stake in shares of Clover Health Investments, Corp. (NASDAQ:CLOV) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 10,324 shares of the company’s stock, valued at approximately $29,000.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Concurrent Investment Advisors LLC purchased a new stake in shares of Clover Health Investments during the third quarter worth about $28,000. Realta Investment Advisors acquired a new position in Clover Health Investments during the third quarter valued at $44,000. Forum Financial Management LP boosted its holdings in Clover Health Investments by 33.8% in the third quarter. Forum Financial Management LP now owns 16,077 shares of the company’s stock valued at $45,000 after purchasing an additional 4,061 shares during the last quarter. Foundations Investment Advisors LLC purchased a new position in shares of Clover Health Investments during the 3rd quarter valued at about $55,000. Finally, Bleakley Financial Group LLC lifted its holdings in shares of Clover Health Investments by 98.9% in the 3rd quarter. Bleakley Financial Group LLC now owns 20,090 shares of the company’s stock valued at $57,000 after buying an additional 9,988 shares during the period. 19.77% of the stock is currently owned by hedge funds and other institutional investors.

Clover Health Investments Price Performance

CLOV opened at $3.04 on Monday. The stock has a market cap of $1.52 billion, a P/E ratio of -15.20 and a beta of 2.03. The firm has a fifty day moving average price of $3.52 and a 200 day moving average price of $2.28. Clover Health Investments, Corp. has a 1 year low of $0.61 and a 1 year high of $4.71.

Clover Health Investments (NASDAQ:CLOV) last posted its earnings results on Wednesday, November 6th. The company reported ($0.02) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.03) by $0.01. Clover Health Investments had a negative net margin of 5.92% and a negative return on equity of 25.46%. The business had revenue of $330.99 million for the quarter, compared to analyst estimates of $347.60 million. During the same period in the prior year, the company posted ($0.09) EPS. Equities analysts expect that Clover Health Investments, Corp. will post -0.12 EPS for the current year.

Analysts Set New Price Targets

Separately, UBS Group assumed coverage on Clover Health Investments in a research report on Monday, October 7th. They set a “neutral” rating and a $4.00 price target for the company.

About Clover Health Investments

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.